Financial information

facts and figures, shareholder 's guide & press releases

Events & financial agenda

Sales figures and results announcements and assembly dates

21 January 2020
Annual sales 2019
22 April 2020
Financial Results 2019
18 June 2020
Shareholders Meeting 2020
27 July 2020
First Half 2020 sales
23 September 2020
Half year results 2020
Shareholders' guide

Listed on Alternext Paris
Eligible PEA PME
Initial listing: 25 April 2014
Number of shares: 15 247 329
ICB Classification (Sector):
4535 Medical Equipment

Identification codes:
Name: THERACLION
ISIN: FR0010120402
LEI: 9695007X7HA7A1GYD29
Ticker: ALTHE
Bloomberg: ALTHE.FP
Reuters: ALTHE.FA

Annual Closure: 31 December

Liquidity contract:
CM-CIC Market Solutions

Analyst coverage:
Farny Meindre CM-CIC Market Solutions
Thibault Voglimacci-Stephanopoli Invest

Latest public analyzes available:

Etude Invest Securities  (in French)

Shareholders
Press releases

Newsworthy statements, milestones and announcements

February 2 2019
Revenu 2018
October 24 2018
Tübingen/Fus
October 2 2018
Progress in Switzerland and Germany
March 16 2015
Publication on Thyroid
March 12 2015
Asia & Nominations
February 12 2015
Publication in JTU
April 3 2014
FDA approval for IDE in USA for Breast Fibroadenoma
December 12 2012
CE Mark breast fibroadenoma
December 12 2012
CE marking approval for Breast Fibroadenoma
Financial reports & presentations

Key economic and financial information
(find more information on the French pages)

Contact us

Move to what moves you - for profit AND for people.
Get in touch